Effect of tirzepatide on oxidative stress and glucose variability in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-jRCT1031230368
- Lead Sponsor
- Ohara Makoto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
a diagnosis of type 2 diabetes mellitus
1) HbA1c 7.0% or more
2) Patients who were treated with regular doses of weekly GLP-1 receptor agonists at least for 12 weeks
3) BMI >= 23
4) written informed consent
5) 20 years and over
Exclusion Criteria
1)the use of steroids or anti-inflammatory drugs,
2)diabetic ketosis and coma within 3 months before the study,
3)severe infection, severe trauma, pre-and post-operation,
4)an estimated glomerular filtration rate are within 30mL/min/1.73m2,
5)malignancy,
6)pregnancy
7)Patients who are judged as inappropriate for inclusion by phsicians
8)Patients using implantable medical devices such as cardiac pacemakers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method